MVT-5873
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MVT-5873, covering 2023-03-21 to 2023-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers [Phase 2]